Faliure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: Potential for rescue?

被引：0
|
作者：
Sobolewski, A. [1 ]
Rudarakanchana, N. [1 ]
Jeffery, T. K. [1 ]
Trembath, R. C. [1 ]
Morrell, N. W. [1 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England
来源：
THORAX | 2006年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：II11 / II11
页数：1
相关论文
共 50 条
  • [21] BETA-ARRESTINS REGULATE SIGNALING BY BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR IN PULMONARY ARTERIAL HYPERTENSION
    Rajagopal, Sudarshan
    Kovacs, Jeff
    Badea, Cristian
    Johnson, G. Allan
    Rockman, Howard A.
    Piantadosi, Claude A.
    Lefkowitz, Robert J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E2046 - E2046
  • [22] Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertension
    Rodriguez-Murillo, Laura
    Subaran, Ryan
    Stewart, William C. L.
    Pramanik, Sreemanta
    Marathe, Sudhir
    Barst, Robyn J.
    Chung, Wendy K.
    Greenberg, David A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : 174 - 180
  • [23] NEUTROPHIL AND REDOX DEPENDENT PROTEOLYSIS OF BONE MORPHOGENETIC PROTEIN 9: POTENTIAL ROLE IN THE PATHOGENESIS OF PULMONARY ARTERIAL HYPERTENSION
    Li, W.
    Hoenderdos, K.
    Salmon, R. M.
    Upton, P. D.
    Condliffe, A. M.
    Chilvers, E. R.
    Morrell, N. W.
    THORAX, 2013, 68 : A146 - A146
  • [24] Idiopathic pulmonary arterial hypertension associated with a novel frameshift mutation in the bone morphogenetic protein receptor II gene and enhanced bone morphogenetic protein signaling A case report
    Choi, Sun Ha
    Jung, Youn-Kwan
    Jang, Ji-Ae
    Han, Seungwoo
    MEDICINE, 2019, 98 (42) : e17594
  • [25] Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension
    Takahashi, H
    Goto, N
    Kojima, Y
    Tsuda, Y
    Morio, Y
    Muramatsu, M
    Fukuchi, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2006, 290 (03) : L450 - L458
  • [26] Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension
    Morty, Rory E.
    Nejman, Bozena
    Kwapiszewska, Grazyna
    Hecker, Matthias
    Zakrzewicz, Anka
    Kouri, Fotini M.
    Peters, Dorothea M.
    Dumitrascu, Rio
    Seeger, Werner
    Knaus, Petra
    Schermuly, Ralph T.
    Eickelberg, Oliver
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (05) : 1072 - 1078
  • [27] The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension Friend and Foe?
    Ormiston, Mark L.
    Godoy, Rafael Soares
    Chaudhary, Ketul R.
    Stewart, Duncan J.
    CIRCULATION RESEARCH, 2019, 124 (06) : 822 - 824
  • [28] Bone Morphogenetic Protein Signaling in Familial Versus Idiopathic Pulmonary Arterial Hypertension.
    Dewachter, L.
    Adnot, S.
    Guignabert, C.
    Tu, L.
    Marcos, E.
    Fadel, E.
    Humbert, M.
    Dartevelle, P.
    Simonneau, G.
    Naeije, R.
    Eddahibi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [29] Right Ventricular Adaptation And Treatment Response In Pulmonary Arterial Hypertension Patients With A Bone Morphogenetic Protein Receptor 2 Mutation
    Van Der Bruggen, C. E. E.
    Trip, P.
    Van De Veerdonk, M.
    Rain, S.
    Handoko, M. L.
    Westerhof, N.
    Van Der Velden, J.
    Noordegraaf, A. Vonk
    Bogaard, H. J.
    Goumans, M.
    De Man, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [30] CATHEPSIN L CONTRIBUTES TO THE DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION VIA DEGRADATION OF BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR
    Peng, Zhouyf
    JOURNAL OF HYPERTENSION, 2018, 36 : E59 - E59
12345